Skip to main content
Erschienen in: Diabetologia 9/2009

01.09.2009 | Article

Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus

verfasst von: L. Ye, K. O. Lee, L. P. Su, W. C. Toh, H. K. Haider, P. K. Law, W. Zhang, S. P. Chan, E. K. W. Sim

Erschienen in: Diabetologia | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We aimed to demonstrate the feasibility and efficacy of intra-muscular transplantation of human skeletal myoblasts (hSkMs) for attenuation of hyperglycaemia and improvement of insulin sensitivity using a mouse model of type 2 diabetes mellitus.

Methods

KK Cg-Ay/J mice, aged 12 to 14 weeks, underwent an initial intraperitoneal glucose tolerance test (GTT) and were divided into the following groups: KK control group, basal medium (M199) only; KK myoblast group, with hSkM transplantation; KK fibroblast group, with human fibroblast transplantation. Non-diabetic C57BL mice were used as an additional normal control and also had hSkM transplantation. Cells were transplanted intra-muscularly into the skeletal muscles of the mice. All animals were treated with ciclosporin for 6 weeks only. HbA1c and fasting GTT, as well as serum adiponectin, cholesterol, insulin and triacylglycerol were studied.

Results

Immunohistochemistry studies showed extensive survival of the transplanted hSkMs in the skeletal muscles at 12 weeks, with nuclei of the hSkMs integrated into the host muscle fibres. Repeat GTT showed a significant decrease in glucose concentrations in the KK myoblast group compared with the KK control and KK fibroblast groups. The KK myoblast group also had reduced mean HbA1c, cholesterol, insulin and triacylglycerol, and increased adiponectin compared with the KK control and KK fibroblast groups. C57BL mice showed no change in glucose homeostasis after hSkM transplant.

Conclusions/interpretation

Human skeletal myoblast transplantation attenuated hyperglycaemia and hyperinsulinaemia and improved glucose tolerance in the KK mouse. This novel approach of improving muscle insulin resistance may be a potential alternative treatment for type 2 diabetes mellitus.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA et al (2001) The continuing increase of diabetes in the US. Diabetes Care 24:412PubMedCrossRef Mokdad AH, Ford ES, Bowman BA et al (2001) The continuing increase of diabetes in the US. Diabetes Care 24:412PubMedCrossRef
2.
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef
3.
Zurück zum Zitat Krone W, Meinertz T (1995) Metabolic syndrome as a cardiovascular risk factor. Herz 20:2–4 (article in German)PubMed Krone W, Meinertz T (1995) Metabolic syndrome as a cardiovascular risk factor. Herz 20:2–4 (article in German)PubMed
4.
Zurück zum Zitat Baudler S, Krone W, Brüning JC (2003) Genetic manipulation of the insulin signalling cascade in mice—potential insight into the pathomechanism of type 2 diabetes. Best Pract Res Clin Endocrinol Metab 17:431–443PubMedCrossRef Baudler S, Krone W, Brüning JC (2003) Genetic manipulation of the insulin signalling cascade in mice—potential insight into the pathomechanism of type 2 diabetes. Best Pract Res Clin Endocrinol Metab 17:431–443PubMedCrossRef
5.
Zurück zum Zitat Guillausseau PJ, Tielmans D, Virally-Monod M, Assayag M (1997) Diabetes: from phenotypes to genotypes. Diabetes Metab 23:14–21PubMed Guillausseau PJ, Tielmans D, Virally-Monod M, Assayag M (1997) Diabetes: from phenotypes to genotypes. Diabetes Metab 23:14–21PubMed
6.
Zurück zum Zitat Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type 2 diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42:146–150PubMedCrossRef Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type 2 diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42:146–150PubMedCrossRef
7.
Zurück zum Zitat Stern MP (1999) Genetic and environmental influences on type 2 diabetes mellitus in Mexican Americans. Nutr Rev 57:S66–S70PubMed Stern MP (1999) Genetic and environmental influences on type 2 diabetes mellitus in Mexican Americans. Nutr Rev 57:S66–S70PubMed
8.
Zurück zum Zitat Zisman A, Peroni OD, Abel ED et al (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924–928PubMedCrossRef Zisman A, Peroni OD, Abel ED et al (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924–928PubMedCrossRef
9.
Zurück zum Zitat Farese RV, Sajan MP, Yang H et al (2007) Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 117:2289–2301PubMedCrossRef Farese RV, Sajan MP, Yang H et al (2007) Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 117:2289–2301PubMedCrossRef
10.
Zurück zum Zitat Koh HJ, Arnolds DE, Fujii N et al (2006) Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26:8217–8227PubMedCrossRef Koh HJ, Arnolds DE, Fujii N et al (2006) Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26:8217–8227PubMedCrossRef
11.
Zurück zum Zitat Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529PubMedCrossRef Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529PubMedCrossRef
12.
13.
14.
Zurück zum Zitat Kim J, Wang ZM, Heymsfield SB, Baumgartner RN, Gallagher D (2002) Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 76:378–383PubMed Kim J, Wang ZM, Heymsfield SB, Baumgartner RN, Gallagher D (2002) Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 76:378–383PubMed
15.
Zurück zum Zitat Iwatsuka H, Shino A, Suzuoki Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17:23–35PubMed Iwatsuka H, Shino A, Suzuoki Z (1970) General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17:23–35PubMed
16.
Zurück zum Zitat Ye L, Haider Kh H, Tan RS et al (2007) Transplantation of nanoparticle transfected skeletal myoblasts over-expressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116:I113–I120PubMedCrossRef Ye L, Haider Kh H, Tan RS et al (2007) Transplantation of nanoparticle transfected skeletal myoblasts over-expressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116:I113–I120PubMedCrossRef
17.
Zurück zum Zitat Ye L, Haider Kh H, Tan RS et al (2008) Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials 29:2125–2137PubMedCrossRef Ye L, Haider Kh H, Tan RS et al (2008) Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials 29:2125–2137PubMedCrossRef
18.
Zurück zum Zitat Lee KS, Kim SR, Park SJ et al (2006) Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol 69:1829–1839PubMedCrossRef Lee KS, Kim SR, Park SJ et al (2006) Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol 69:1829–1839PubMedCrossRef
19.
Zurück zum Zitat Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486PubMed Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486PubMed
20.
Zurück zum Zitat Ferrannini E (1997) Insulin resistance is central to the burden of diabetes. Diabetes Metab Rev 13:81–86PubMedCrossRef Ferrannini E (1997) Insulin resistance is central to the burden of diabetes. Diabetes Metab Rev 13:81–86PubMedCrossRef
21.
Zurück zum Zitat Zierath JR, Krook A, Wallberg-Henriksson H (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821–835PubMedCrossRef Zierath JR, Krook A, Wallberg-Henriksson H (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821–835PubMedCrossRef
22.
Zurück zum Zitat Law PK, Goodwin TG, Fang Q et al (1997) First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell Transplant 6:95–100PubMedCrossRef Law PK, Goodwin TG, Fang Q et al (1997) First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell Transplant 6:95–100PubMedCrossRef
23.
Zurück zum Zitat Bischoff R, Heintz C (1994) Enhancement of skeletal muscle regeneration. Dev Dyn 201:41–54PubMed Bischoff R, Heintz C (1994) Enhancement of skeletal muscle regeneration. Dev Dyn 201:41–54PubMed
24.
Zurück zum Zitat Karpati G, Pouliot Y, Carpenter S (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23:64–72PubMedCrossRef Karpati G, Pouliot Y, Carpenter S (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 23:64–72PubMedCrossRef
25.
Zurück zum Zitat Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176–179PubMedCrossRef Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337:176–179PubMedCrossRef
26.
Zurück zum Zitat Morgan JE, Hoffman EP, Partridge TA (1990) Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 111:2437–2449PubMedCrossRef Morgan JE, Hoffman EP, Partridge TA (1990) Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 111:2437–2449PubMedCrossRef
27.
Zurück zum Zitat Morris F, White C, Ronald K (1994) Insulin signaling system. J Biol Chem 269:1–4 Morris F, White C, Ronald K (1994) Insulin signaling system. J Biol Chem 269:1–4
28.
Zurück zum Zitat Watt DJ, Morgan JE, Partridge TA (1984) Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 7:741–750PubMedCrossRef Watt DJ, Morgan JE, Partridge TA (1984) Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve 7:741–750PubMedCrossRef
29.
Zurück zum Zitat Watt DJ, Morgan JE, Clifford MA, Partridge TA (1987) The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat Embryol 175:527–536PubMedCrossRef Watt DJ, Morgan JE, Clifford MA, Partridge TA (1987) The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat Embryol 175:527–536PubMedCrossRef
30.
Zurück zum Zitat Gussoni E, Wang Y, Fraefel C et al (1996) A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol 14:1012–1016PubMedCrossRef Gussoni E, Wang Y, Fraefel C et al (1996) A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol 14:1012–1016PubMedCrossRef
31.
Zurück zum Zitat Gussoni E, Blau HM, Kunkel LM (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970–977PubMedCrossRef Gussoni E, Blau HM, Kunkel LM (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970–977PubMedCrossRef
Metadaten
Titel
Skeletal myoblast transplantation for attenuation of hyperglycaemia, hyperinsulinaemia and glucose intolerance in a mouse model of type 2 diabetes mellitus
verfasst von
L. Ye
K. O. Lee
L. P. Su
W. C. Toh
H. K. Haider
P. K. Law
W. Zhang
S. P. Chan
E. K. W. Sim
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 9/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1421-9

Weitere Artikel der Ausgabe 9/2009

Diabetologia 9/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.